Conference abstract · 20 Oct 2014
CommentaryPublished 29 Apr 2025
Immunotherapy’s Future: Novel Agents, Combinations and Personalization
Similar by topic
Short communication · 29 Oct 2025
Optimizing Combination Immunotherapy Clinical Trials In Cancer
Conference abstract · 2 Oct 2017
Novel sensitive sensors of intracellular viscosity and potential anticancer theranostic agents prepared on the porphyrazine pigments platform for specifically personalized medicine.
Mini review · 26 Aug 2022
Immunotherapy of Glioblastoma: Recent Advances and Future Possibilities
Conference abstract · 18 Jul 2022
Novel synthesis of four scaffolds of quinolone hydrazide hybrid drugs and comparing their biological activities as breast cancer agents
More from this journal
The newest in Journal of Cancer Clinical Trials.
Article · 26 Oct 2026
Leveraging Artificial Intelligence to Structure Next-Generation Sequencing Data for Precision Oncology Research: A Real-World Pancreatic Ductal Adenocarcinoma Liquid Biopsy Experience
Article · 3 Jul 2026
The Current Status of Adjuvant Chemotherapy for Colorectal Cancer in Japan: A Paradigm Shift from Oral Fluoropyrimidine Monotherapy to Oxaliplatin-Based Regimens
Brief report · 29 Dec 2025
Validating Cancer Biomarkers: Challenges and Precision Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cancer Clinical Trials
- SubjectOncology & Cancer
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sophie Laurent”

